The current derogation from marking GB packs as exported has been extended. Currently, it has been extended for one year (i.e. to Dec 31st, 2022) but it is known that this will then be extended until 2024 by means of an amendment to the DR.
As such OBPs should no longer be thinking of marking packs for the GB market as Exported – they should be sent as Active until the end of next year.
Feel free to go through the document below for further information
For further clarification on this article please feel free to contact the EMVO Service Desk at helpdesk@emvo-medicines.eu